HEXO (NYSE:HEXO,TSX:HEXO) announced Thursday (July 18) that Adam Miron, co-founder of the company, has decided to step down as chief brand officer effective immediately.

As quoted in the press release:


Adam Miron co-founded HEXO six years ago with Sebastien St-Louis and has played a key role not only in building the company, but as an innovative leader in the cannabis industry. Adam will retain his seat on the HEXO Board of Directors and will continue to serve as President of the Board of Directors of HEXO MED, the Company’s Greek affiliate.

“Building HEXO has been one of the greatest privileges of my life,” said HEXO co-founder, Adam Miron. “I am a builder. What I see today is an established company with amazing leadership across all functions. I would like to thank the entire team and all our supporters for making this possible.”

“Adam’s vision, passion, keen sense of business, marketing and leadership were pivotal in the creation, growth and success of HEXO,” said HEXO’s Chairman of the Board of Directors, Dr. Michael Munzar. “We thank Adam for his dedication to HEXO in the past and look forward to having him play a more active role on the Board as he continues to guide the company’s success.”

Click here to read the full press release.

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less